Merck Reports Second-Quarter 2008 Financial Results (Business Wire)

Monday July 21, 4:37 pm ET -- Company Announces Second-Quarter 2008 Non-GAAP EPS of $0.86, Excluding Certain Items; Second-Quarter GAAP EPS of $0.82-- JANUVIA, ISENTRESS and COZAAR/HYZAAR Deliver Strong Growth-- U.S. Food and Drug Administration (FDA) Closes Out Manufacturing Warning Letter; Any Filed Vaccine Supplements Are Now Able To Move Through The Agency's Normal Review and Approval Process -- Merck Updates Full-Year 2008 Product and Certain Other Guidance Elements; At This Time Not Providing 2008 Equity Income, 2008 EPS, and Long-Term Guidance WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. today announced financial results for the second quarter of 2008. Merck reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) of $0.86 for the second quarter of 2008, excluding... [read full story]